Compare ALT & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ALT | PRE |
|---|---|---|
| Founded | 1997 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | 98 |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Laboratory Analytical Instruments |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 421.5M | 337.6M |
| IPO Year | 2005 | N/A |
| Metric | ALT | PRE |
|---|---|---|
| Price | $2.76 | $20.13 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 2 |
| Target Price | $17.67 | ★ $30.50 |
| AVG Volume (30 Days) | ★ 2.8M | 265.1K |
| Earning Date | 05-08-2026 | 06-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 25.37 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $41,000.00 | N/A |
| Revenue This Year | N/A | $108.69 |
| Revenue Next Year | N/A | $58.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 105.00 | N/A |
| 52 Week Low | $2.56 | $7.18 |
| 52 Week High | $7.73 | $23.63 |
| Indicator | ALT | PRE |
|---|---|---|
| Relative Strength Index (RSI) | 42.50 | 55.34 |
| Support Level | $2.57 | $17.44 |
| Resistance Level | $4.19 | $21.03 |
| Average True Range (ATR) | 0.12 | 1.53 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 27.34 | 58.05 |
Altimmune Inc is a late clinical-stage biopharmaceutical company developing therapies for patients with serious liver diseases. The Company's key candidate, pemvidutide, is a dual-action therapy targeting both glucagon and GLP-1 receptors in a balanced 1:1 ratio in development for the treatment of metabolic dysfunction-associated steatohepatitis (MASH), alcohol use disorder (AUD), and alcohol-associated liver disease (ALD). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.
Prenetics Global Ltd is a health sciences company dedicated to advancing consumer health. The consumer initiative is led by IM8, one of the world's fastest-growing supplement brands; Europa, one of the sports distribution companies in the USA; and CircleDNA, a direct-to-consumer DNA testing company. As the first consumer healthcare company to establish a Bitcoin treasury with its initial approximately $20 million Bitcoin purchase and board-approved comprehensive Bitcoin plan of action, Prenetics is pioneering the intersection of healthcare innovation and digital asset adoption.